(Q44662272)

5 December 2017

title

Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma (English)

1 reference

5 December 2017

9

Paul G Richardson

1 reference

5 December 2017

10

Kenneth C Anderson

1 reference

5 December 2017

8

Nikhil C Munshi

1 reference

5 December 2017

2

Dharminder Chauhan

1 reference

5 December 2017

1

Teru Hideshima

1 reference

5 December 2017

7

Klaus Podar

1 reference

5 December 2017

Constantine S Mitsiades

series ordinal

6

object named as

Constantine Mitsiades

1 reference

5 December 2017

5

Nicholas Mitsiades

1 reference

5 December 2017

4

Masaharu Akiyama

1 reference

5 December 2017

Toshiaki Hayashi

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

22

1 reference

5 December 2017

issue

52

1 reference

5 December 2017

page(s)

8386-8393

1 reference

Oncostatin M induces association of Grb2 with Janus kinase JAK2 in multiple myeloma cells

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

Activation of Fes tyrosine kinase by gp130, an interleukin-6 family cytokine signal transducer, and their association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

Interleukin-6-induced tyrosine phosphorylation of multiple proteins in murine hematopoietic lineage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Cytochrome c-dependent and -independent induction of apoptosis in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

NF-kappa B as a therapeutic target in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

The gp 130 family cytokines IL‐6, LIF and OSM but not IL‐11 can reverse the anti‐proliferative effect of dexamethasone on human myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207170

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207170

1 reference

5 December 2017

1 reference